Heart Disease Trial, Recruiting NCT07518030 Sponsor: Azienda Unita Sanitaria Locale di Piacenza Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07518030
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged 18 or older
  • People who have recently been diagnosed with a type of heart failure called HFrEF (where the heart's pumping function is reduced), whether that diagnosis was made in hospital or at a clinic
  • People who have not yet started any standard heart failure medications, or who are taking only one medication that was prescribed for a different health condition
  • People who are able to use electronic devices — such as a phone or tablet — to make calls, record measurements like weight and blood pressure, and use digital health tools; if the person themselves finds this difficult, a family member or carer who can help with this is also acceptable
  • People whose heart failure is caused by any underlying reason, including blocked arteries, heart valve problems, inherited or infiltrative heart muscle conditions, medication side effects, toxic causes, or a fast heart rate causing heart muscle weakness

Who may not be able to join:

  • People who are already taking two or more guideline-based heart failure medications at the time their HFrEF is diagnosed
  • People with serious other health conditions or who are medically unstable in a way that requires long-term or ongoing hospital care
  • People whose life expectancy is estimated to be less than 12 months
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: + 39 0523 302208

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Unita Sanitaria Locale di Piacenza
Registry
ClinicalTrials.gov
Start date
20 March 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in guideline-directed medical therapy (GDMT) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov